NCT04848818

Brief Summary

The study is designed as a multicenter trial for the treatment of distal pediatric forearm fractures (=severely displaced distal metaphyseal forearm fractures) with a PLGA-based biodegradable intramedullary implant in children. The primary objective of the trial is to evaluate clinical outcome between Activa IM-Nail™ and K-wire in this indication. The secondary objective is to evaluate potential differences of potential complications in the operative method with either a biodegradable intramedullary PLGA-implant or with conventional K-wires. K-wire osteosynthesis will be made according to the conventional surgical technique by three paediatric trauma centers. Intramedullary PLGA implantation will be made by the Péterfy Hospital. The surgical indication will be the same in all groups, and follow-up will follow standard protocols. In the further clinical course, the patients in the study group treated with PLGA implants spare a subsequent operation for implant removal after 4-8 weeks. The results of different surgeries will be compared based on several criteria.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
164

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2020

Typical duration for not_applicable

Geographic Reach
1 country

4 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 8, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 19, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

April 19, 2021

Status Verified

March 1, 2021

Enrollment Period

2 years

First QC Date

April 8, 2021

Last Update Submit

April 13, 2021

Conditions

Keywords

childrenradiusfracturewirebioabsorbable

Outcome Measures

Primary Outcomes (1)

  • Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ correlate to less complications than the conventional K- wiring technique in displaced pediatric distal forearm or radial metaphyseal fractures?

    We compare the incidence of minor and major complications of both surgical technique. These are: superficial skin infection, tendon injury, nerve injury, secondary displacement, deep infection, skin irritation.

    Six months after operation

Secondary Outcomes (5)

  • Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative immobilisation time?

    Eight weeks after operation

  • Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ not require a second intervention?

    Six months after operation

  • Does the short intramedullary nailing operative method with bioabsorbable Activa IM Nails™ also reduce the postoperative outpatient visits?

    1 year after operation

  • Does the short intramedullary nailing operative method with biodegradable nails and K-wire technique results a full recovery of the functions within six months?

    Six months after operation

  • Does the short intramedullary nailing operative method with biodegradable nails shortens the recovery time for the full function compared to the K-wiring method?

    Six months after surgey

Study Arms (2)

K-wire group

ACTIVE COMPARATOR

Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13.

Procedure: Distal radial metaphyseal fracture fixation with percutaneous K-wires

Activa-IM Nail group

ACTIVE COMPARATOR

Children with closed or grade I. open, severly displaced distal radial and/or complete forearm metaphyseal fractures between the age 3-13.

Procedure: Distal radial and/or ulnar metaphyseal fracture fixation with bidegradable PLGA-based (Activa Im-Nail) implants

Interventions

Pediatric distal metaphyseal fractures which are severly displaced will be operated with percutaneous K-wires..

K-wire group

Pediatric distal metaphyseal radial and /or ulnar fractures which are severly displaced will be operated with percutaneous bidegradable PLGA-based (Activa Im-Nail) implants.

Activa-IM Nail group

Eligibility Criteria

Age3 Years - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Clinical diagnosis of distal radial or complete forearm fracture Metaphyseal radial/or distal forearm fractures with complete displacement and shortening.
  • Age between of 3-13 years. Open physeal plates on X-rays. Closed or Grade I. open fractures Ability and willingness to give an informed consent

You may not qualify if:

  • Pathological fractures (e.g. bone cyst) Poly-traumatized patient Inability or unwillingness to give informed consent Closed physeal plates on X-rays. Active skin infection in the surgical area

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Szent János Hospital

Budapest, Diós Árok 1., 1125, Hungary

RECRUITING

Péterfy Hospital

Budapest, Fiumei Út 17, 1081, Hungary

RECRUITING

Medical University of Pécs, Pediatric Surgery

Pécs, József Attila U 7., 7623, Hungary

RECRUITING

Heim Pál Hospital

Budapest, Üllöi Út 86, 1089, Hungary

RECRUITING

MeSH Terms

Conditions

Wrist FracturesFractures, Bone

Interventions

Drug Implants

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and Injuries

Intervention Hierarchy (Ancestors)

Delayed-Action PreparationsDosage FormsPharmaceutical Preparations

Study Officials

  • Marcell Varga, PhD

    Péterfy Hospital, National Trauma Center,Budapest

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marcell Varga, PhD

CONTACT

Tamás Kassai, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2021

First Posted

April 19, 2021

Study Start

March 1, 2020

Primary Completion

March 1, 2022

Study Completion

October 1, 2022

Last Updated

April 19, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations